Sponsor:
University of Iowa
Code:
NCT06489249
Conditions
Electronic Cigarette Use
Endothelial Dysfunction
Inflammation
Eligibility Criteria
Sex: All
Age: 18 - 24
Healthy Volunteers: Accepted
Interventions
Placebo
Salsalate 750 MG Oral Tablet [DISALCID]
Brief summary:
Conditions
Electronic Cigarette Use
Endothelial Dysfunction
Inflammation
Study ID
NCT06489249
Start date
Aug 15, 2024
Status verified date
Dec, 2025
Completion date
Oct, 2026
Anticipated
Primary completion date
Jun, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 24
Healthy Volunteers: Accepted
Enrollment
24 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Basic Science
Arms
experimental: Placebo then Salsalate
experimental: Salsalate then Placebo
Interventions
Placebo
Salsalate 750 MG Oral Tablet [DISALCID]
Primary outcome measure
Central contacts
Locations
Iowa Bioscience Innovation Facility
Recruiting
Iowa City, Iowa, United States, 52242
Contacts
University of Iowa
Recruiting
Iowa City, Iowa, United States, 52242
Contacts
Sponsor
University of Iowa
Last update posted
Dec 15, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Iowa on 2025-12-15.